Clearside Biomedical, Inc. (CLSD) Social Stream
Clearside Biomedical Inc (CLSD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CLSD.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 159 days, CLSD's average price target has gone down $0.6.
Over the past 51 weeks, CLSD's average upside potential has been 127.35%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CLSD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 35 weeks, CLSD's average broker recommendation rating improved by 0.4.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Clearside Biomedical Inc's upside potential (average analyst target price relative to current price) is greater than 289.3% of them.
- To contextualize these metrics, consider that out of all US stocks, Clearside Biomedical Inc's variance in analysts' estimates is lower than -184.9% of them.
- To contextualize these metrics, consider that out of all US stocks, Clearside Biomedical Inc's average analyst price target is greater than 31.14% of them.
- In terms of how Clearside Biomedical Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 197.7% of that group.
In the Pharmaceutical Products industry, CLNN, CKPT, and CELU are the three stocks most similar to Clearside Biomedical Inc regarding the price target and analyst recommendation information presented here.
Is CLSD a Buy, Hold or Sell? See the POWR Ratings now!